Middle East & Africa Next Generation Sequencing (NGS) Market to 2032
Overview
The Middle East & Africa Next Generation Sequencing (NGS) Market is expected to reach a 3,138.04 USD Billion by 2032 and is projected to grow at a CAGR of 16.27% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1,292.22
Forecast, 2032 (USD Billion)
3,138.04
CAGR, 2024 - 2032
16.27%
Report Coverage
Middle East & Africa
Middle East & Africa Next Generation Sequencing (NGS) Market 2018-2032 USD Billion
Middle East & Africa Next Generation Sequencing (NGS) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1,292.22 USD Billion
- Projected Market Size (2032): 3,138.04 USD Billion
- CAGR (2025-2032): 16.27%
Key Findings of Middle East & Africa Next Generation Sequencing (NGS) Market
- The Middle East & Africa Next Generation Sequencing (NGS) Market was valued at 3,138.04 USD Billion in 2024.
- The Middle East & Africa Next Generation Sequencing (NGS) Market is likely to grow at a CAGR of 16.27% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Pharmaceuticals Microbiology in Application Segment accounted for the largest share of the market with a revenue of 1,319.73 USD Billion
- The fastest growing segment Services in Product & Service Segment grew Fastest with a CAGR of 17.72% during the forecast period from 2024 to 2032.
Middle East & Africa Next Generation Sequencing (NGS) Market Scope
Middle East & Africa Next Generation Sequencing (NGS) Market Segmentation & Scope
Technology
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
Application
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Drug & Biomarker Discovery
- Precision Medicine
- Pharmaceuticals Microbiology
Product & Service
- Instruments
- Services
- Consumables
End User
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Middle East & Africa Next Generation Sequencing (NGS) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1,292.22 USD Billion |
| Market Value in 2032 | 3,138.04 USD Billion |
| CAGR (2025-2032) | 16.27% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Technology,Application,Product & Service,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 1,292.22 USD Billion in 2024
- Key Country: South Africa, leading in terms of revenue with value of 330.09 USD Billion in 2024.
Segments and Scope
-
Middle East & Africa Next Generation Sequencing (NGS) Market to 2032, By Technology
- Sequencing By Synthesis (SBS) is the largest segment in Middle East & Africa Next Generation Sequencing (NGS) Market to 2032 with a revenue of 949.22 USD Billion in the year 2024.
- Sequencing By Synthesis (SBS) is the Fastest growing segment in Middle East & Africa Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 16.35 % in forecast period 2025-2032.
-
Middle East & Africa Next Generation Sequencing (NGS) Market to 2032, By Application
- Pharmaceuticals Microbiology is the largest segment in Middle East & Africa Next Generation Sequencing (NGS) Market to 2032 with a revenue of 1,319.73 USD Billion in the year 2024.
- Pharmaceuticals Microbiology is the Fastest growing segment in Middle East & Africa Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 16.72 % in forecast period 2025-2032.
-
Middle East & Africa Next Generation Sequencing (NGS) Market to 2032, By Product & Service
- Consumables is the largest segment in Middle East & Africa Next Generation Sequencing (NGS) Market to 2032 with a revenue of 855.65 USD Billion in the year 2024.
- Services is the Fastest growing segment in Middle East & Africa Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 15.93 % in forecast period 2025-2032.
-
Middle East & Africa Next Generation Sequencing (NGS) Market to 2032, By End User
- Pharmaceutical & Biotechnology Companies is the largest segment in Middle East & Africa Next Generation Sequencing (NGS) Market to 2032 with a revenue of 759.98 USD Billion in the year 2024.
- Pharmaceutical & Biotechnology Companies is the Fastest growing segment in Middle East & Africa Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 16.60 % in forecast period 2025-2032.
-
Middle East & Africa Next Generation Sequencing (NGS) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Middle East & Africa Next Generation Sequencing (NGS) Market to 2032 with a revenue of 945.89 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in Middle East & Africa Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 16.37 % in forecast period 2025-2032.
Middle East & Africa Next Generation Sequencing (NGS) Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Charles River Laboratories | |||
Middle East & Africa Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion
Middle East & Africa Next Generation Sequencing (NGS) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Next Generation Sequencing (NGS) Market is segmented based on Segmentation Technology,Application,Product & Service,End User,Distribution Channel.
Middle East & Africa Next Generation Sequencing (NGS) Market was valued at USD 1,292.22(Revenue in USD Billion) in 2020.
Middle East & Africa Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 16.27% during the forecast period of 2024 to 2032.
The Pharmaceuticals Microbiology segment is expected to dominate the Middle East & Africa Next Generation Sequencing (NGS) Market, holding a largest market share of 1,319.73 USD Billion in 2024
Coming Soon....
Middle East & Africa Next Generation Sequencing (NGS) Market Scope
Middle East & Africa Next Generation Sequencing (NGS) Market Segmentation & Scope
Technology
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
Application
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Drug & Biomarker Discovery
- Precision Medicine
- Pharmaceuticals Microbiology
Product & Service
- Instruments
- Services
- Consumables
End User
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Distribution Channel
- Others
- Retail Sales
- Direct Tender
Frequently Asked Questions
The Middle East & Africa Next Generation Sequencing (NGS) Market is segmented based on Segmentation Technology,Application,Product & Service,End User,Distribution Channel.
Middle East & Africa Next Generation Sequencing (NGS) Market was valued at USD 1,292.22(Revenue in USD Billion) in 2020.
Middle East & Africa Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 16.27% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Next Generation Sequencing (NGS) Market for final year is USD 3,138.04 (USD Billion).
Middle East & Africa Next Generation Sequencing (NGS) Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Next Generation Sequencing (NGS) Market is segmented based on Segmentation Technology,Application,Product & Service,End User,Distribution Channel.
Middle East & Africa Next Generation Sequencing (NGS) Market was valued at USD 1,292.22(Revenue in USD Billion) in 2020.
Middle East & Africa Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 16.27% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Next Generation Sequencing (NGS) Market for final year is USD 3,138.04 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.